Also trades as: YATHARTH.BO (BSE) · $vol 0M
YATHARTH.NS NSE
Yatharth Hospital & Trauma Care Services Limited
1W: -10.7%
1M: +6.0%
3M: +19.4%
YTD: +52.8%
1Y: +44.6%
₹1,001.00 ($10.40)
-32.70 (-3.16%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$12.1B
+37.1% ▲
5Y CAGR: +39.5%
Gross Profit
$6.5B
+20.5% ▲
5Y CAGR: +29.0%
Operating Income
$2.0B
+25.3% ▲
5Y CAGR: +33.9%
Net Income
$1.8B
+34.3% ▲
5Y CAGR: +57.4%
EPS (Diluted)
$18.20
+23.6% ▲
5Y CAGR: +45.7%
EBITDA
$2.9B
+23.6% ▲
5Y CAGR: +34.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4.0B | $5.2B | $6.7B | $8.8B | $12.1B |
| YoY Growth | +75.3% | +29.8% | +28.9% | +31.3% | +37.1% |
| Cost of Revenue | $813M | $929M | $1.3B | $3.4B | $5.6B |
| Gross Profit | $3.2B | $4.3B | $5.4B | $5.4B | $6.5B |
| Gross Margin | 79.7% | 82.1% | 80.1% | 61.3% | 53.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $19M | $65M | $75M | $3.2B | $4.5B |
| Operating Expenses | $2.4B | $3.2B | $980M | $3.8B | $4.5B |
| Operating Income | $841M | $1.1B | $1.5B | $1.6B | $2.0B |
| Operating Margin | 21.0% | 20.9% | 23.1% | 18.5% | 16.9% |
| Interest Expense | $219M | $220M | $114M | $75M | $65M |
| Income Before Tax | $631M | $877M | $1.6B | $1.7B | $2.2B |
| Tax Expense | $189M | $219M | $424M | $412M | $533M |
| Net Income | $442M | $658M | $1.1B | $1.3B | $1.8B |
| Net Margin | 11.0% | 12.6% | 17.1% | 14.8% | 14.5% |
| EPS (Diluted) | $6.74 | $10.04 | $14.46 | $14.72 | $18.20 |
| EBITDA | $1.1B | $1.4B | $2.0B | $2.4B | $2.9B |
| Shares Outstanding | 86M | 86M | 79M | 85M | 96M |